Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 June 2022 | Story Nonsindiso Qwabe | Photo Supplied
Enactus Qwaqwa Campus
Owning Their Future – Enactus students on the Qwaqwa Campus.

Empowered by the Enactus platform, a group of students on the Qwaqwa Campus are planting seeds of lifelong goodness in the Qwaqwa community.

Enactus is an international non-profit organisation that equips students to improve the world through entrepreneurial action by providing a platform for teams of outstanding students to create community development projects that put communities at the centre of improving their own livelihoods.

The group of seven students, namely Salima van Schalkwyk, Lehlohonolo Mokoena, Tubatse Moloi, Jennifer Links, Boikanyo Madisha, Bonagani Makwakwa, and Vuyo Mbamba, who are all pursuing undergraduate degrees in various disciplines, form part of Enactus.

Van Schalkwyk, the team leader and second-year Bachelor of Community Development student, said being part of Enactus has enabled them to make a tangible difference in the community around them.

“[As a team], we always assumed we knew what people go through on a daily basis, but we were in for a surprise. Despite the beautiful mountainous views of Qwaqwa, the people are in pain, one that is a cycle. When we look at all that we have discovered, all that we have heard and seen, we are moved to give the people of Qwaqwa a hand in being lifted to the surface.”

Leaving footprints of greatness for future generations

The team is currently competing in various competitions that seek to bring about social change. In 2021, the team was selected by MTN ICT as part of the top 12 nominees countrywide, receiving funding to develop an app that will assist students with mental health challenges. Apart from developing the app, they are also working on 7 Seeds, an agricultural enterprise that seeks to address the agricultural difficulties of a farm they identified in Qwaqwa.

Van Schalkwyk said they will be participating in the Enactus National Competition on 14 July 2022 and are gunning for the Enactus World Cup that will take place in Puerto Rico in October this year.

“Our vision as Enactus students is to create a better, more sustainable world for future generations. In the current economic situation our country is in, we believe that social entrepreneurship is the key to economic development and empowerment. Through Enactus, we hope to inspire many more students to submerge themselves in entrepreneurial activities. We live to leave footprints that lead to greatness for future generations,” she said.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept